[Skip to Content]
[Skip to Content Landing]
Article
January 19, 1994

No Structural Mutation in the Dopamine D2 Receptor Gene in Alcoholism or SchizophreniaAnalysis Using Denaturing Gradient Gel Electrophoresis

Author Affiliations

From the Clinical Neurogenetics Branch (Drs Gejman, Ram, Cao, and Gershon and Mr Whitsitt) and Experimental Therapeutics Branch (Dr Pickar), National Institute of Mental Health, Bethesda, Md; Department of Psychiatry, Yale University Medical Center, New Haven, Conn, and West Haven Department of Veterans Affairs Medical Center, West Haven, Conn (Drs Gelernter, O'Malley, and Rao); Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden (Dr Friedman); Department of Pharmacology, The University of Texas Health Science Center at San Antonio (Dr Blum); Alcohol Research Center, UCLA Neuropsychiatric Institute and Brain Research, Los Angeles, Calif (Dr Noble); Alcohol Research Center, The University of Connecticut Health Center, Farmington (Dr Kranzler); Laboratory of Biochemistry, National Cancer Institute, Bethesda, Md (Dr Hamer); Department of Psychiatry and Behavioral Science, Health Sciences Center, State University of New York, Stony Brook (Dr DeLisi); Department of Psychiatry, University of Helsinki (Finland) (Dr Virkkunen); Laboratory of Clinical Studies, Division of Intramural Clinical and Biological Research (Dr Linnoila), and Laboratory of Neurogenetics (Dr Goldman), National Institute on Alcohol Abuse and Alcoholism, Bethesda, Md.

JAMA. 1994;271(3):204-208. doi:10.1001/jama.1994.03510270050038
Abstract

Objective.  —To examine the dopamine D2 receptor (DRD2) gene coding sequences for abnormalities associated with schizophrenia or alcoholism and thereby help to resolve the controversy surrounding the reported association of alcoholism with a restriction fragment length polymorphism located close to the DRD2 gene.

Design.  —Mutational analysis of complete DRD2 gene coding sequences by denaturing gradient gel electrophoresis followed by direct nucleotide sequencing of detected variants.

Setting.  —Patients and controls from clinical and epidemiologic collections in the United States and Europe.

Patients.  —A total of 253 unrelated individuals, including 106 patients with schizophrenia, 113 with alcoholism, and 34 controls. For alcoholism we included patients from previously published series in which an association of illness with allele A1 was reported (Taq site 3' to the DRD2gene) and from other published series in which nonconfirmations of this association were reported. Nearly all persons examined were white.

Main Outcome Measures.  —Frequency of nonsilent variations in DRD2 gene DNA sequences in the different diagnostic groups.

Results.  —We found three infrequent DNA variants that predict altered amino acid sequence of the receptor. None of these is associated with either alcoholism or schizophrenia.

Conclusion.  —No structural coding abnormalities in the DRD2gene are present in alcoholism or schizophrenia.(JAMA. 1994;271:204-208)

×